04 May 2007
Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients
Mahmood Hadipour Dehshal, Amir Hooshang Hooghooghi, Abbas Kebryaeezadeh, Morteza Kheirabadi, Shahram Kazemi, Azadeh Nasseh, Ahmad Shariftabrizi, Parvin PasalarMed Sci Monit 2007; 13(5): CR235-239 :: ID: 484604
Abstract
Background: The aim was to determine whether reduced serum zinc level has a contributory effect on impairment of insulin secretion in β-thalassemic patients with transfusion-induced iron overload.
Material/Methods: Seventy thalassemia patients who received deferoxamine chelation therapy and 69 healthy individuals as the control group were evaluated. A standard oral glucose tolerance test (OGTT) was performed
and blood samples for measurement of serum ferritin, zinc, and insulin concentrations were obtained.
Results: Although the fasting serum insulin concentrations were quite similar between the patient and the control groups, serum insulin levels were signifi cantly lower in the thalassemia patients one hour and two hours after oral glucose load ingestion compared with the healthy controls. Among the
thalassemic adults, zinc defi ciency (present in 37% of patients) resulted in signifi cantly lower fasting and 1-hour post-OGTT serum insulin concentrations. The serum zinc level in patients with impaired OGTT was also considerably lower than in patients with normal OGTT.
Conclusions: These data support the assumption that zinc defi ciency might lead to an exacerbation of the inability of the pancreas to secrete suffi cient amounts of insulin in response to glucose stimulation in β-thalassemia patients. We suggest that serum zinc levels be routinely monitored in these patients as it might provide useful complementary information regarding glucose metabolism.
Keywords: Chelating Agents - therapeutic use, Adolescent, Deferoxamine - therapeutic use, Ferritins - blood, Glucose - metabolism, Glucose Tolerance Test, Insulin - metabolism, Siderophores - therapeutic use, Zinc - deficiency, beta-Thalassemia - metabolism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952